USPTO serial 75173002
PHILD
Reviewed by CopyMark Law Group
Reg. 2322684Status 710
- Filing date
- Status date
- Registration date
- Feb 29, 2000
- Examiner
- SALEMI, DOMINICK
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHILD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kamigyo-ku, Kyoto-city, Kyoto Pref., JP
Kamigyo-ku, Kyoto-city, Kyoto Pref., JP
Kyoto city, Kyoto Pref., JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARY FRANCES LOVE
STACEY R HALPERN KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN ST 14TH FLIRVINE, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals for use in the manufacture of pharmaceuticals, germination controllers and hormones for plants, plant rearing and soil improving preparations | SECTION 8 - CANCELLED | — |
| 003 | hair remedies and bath preparations; preparations for dental use, namely, toothpaste; Astringents for cosmetic purposes; medicated soap of the Japanese pharmacopedia | SECTION 8 - CANCELLED | — |
| 005 | absorbent cotton for medical purposes; adhesive medical plaster; bandages for dressings; capsules for medical purposes and nutritional purposes, namely, nutrient supplements comprising vitamins and carbohydrates for keeping health of the liver; dental preparations, namely, dental cements, dental prosthetic and filling materials, dental wax and artificial tooth material; drugs for medical purposes, namely, drugs for central nervous system, namely, general anesthetics, hypnotics and sedatives, anti-epileptics, antipyretics and analgesics, nervous system stimulants, analeptics and anti-dizziness preparations; drugs for peripheral nervous system, namely, local anesthetics, skeletal muscle relaxants, autonomics, antispasmodics, diaphoretics and anhidrotics; drugs for sensory organs, namely, preparations for ophthalmic use and preparations for optic and nasal use; drugs used in allergy, namely, anti-histaminics and preparations for stimulation therapy; drugs affecting circulatory organs, namely, cardiotonics, preparations for arrhythmia, diuretics, hypotensors, vasosupporters, vasoconstrictors and cerebral hemorrhage prophylactic; preparations affecting respiratory organs, namely, respiratory stimulants, antitussives and expectorants and cough wheat gluten; preparations for digestive organs, namely, preparations for oral use for the treatments of the inflammations of the oral mocosa, stomachics and digestives, antacids, anti-emetics, emetics, choleretics, antidiarrheals, purgatives, clysters, stomach and bowels wash powder, tooth prophylactic, stomatic refrigerant, and stomatic cleanser; hormone preparations, namely, pituitary hormone preparations, salivary gland hormone preparations, thyroid and accessory thyroid hormone preparations, pancreas hormone preparations, adrenal hormone preparations, androgens, estrogens and mixed hormone preparations; preparations for urinary, genital and anal organs, namely, urinary antiseptics, oxytocics, preparations affecting menstruation, contraceptives and anti-hemorrhoidics; preparations affecting epidermis, namely, disinfectants, dermatics for purulence, analgesics, anti-itchings, cataplasms, anti-dermoinfectives, corrosives, medicated baby powder, medicated baby oil; vitamin preparations for use as dietary supplements, namely, vitamin A preparations, vitamin B preparations, vitamin C preparations, vitamin D preparations, composite vitamin preparations compounded of water soluble and fat soluble vitamins, mixed vitamin preparations compounded of water soluble and fat soluble vitamins and cod-liver oil drops; amino acids and preparations for use as dietary supplements for keeping health, namely, lysine, methionin, tryptophane and threonine; nutrients, tonics and alternatives, namely, nutrients, tonics, alternatives for use as dietary supplements for keeping health, namely, calcium preparations, mineral agents, saccharide preparations, organic acid preparations, proteins, amino acids and preparations, organotherapeutics, chondroitin preparations, foodstuff solidifying agent, medicated wine and royal jelly; preparations relating to blood, namely, blood substitutes for medical use, hemostatics, anticoagulants and blood-plasma; preparations affecting metabolism, namely, lipotropic factor preparations, preparations for treatment of habitual intoxication, lactogoques and enzyme preparations; preparations for activating cellular function, namely, chlorophyll preparations and dyes; tumor suppressing preparations, namely, anti-cancer preparations and anti-sarcoma preparations; preparations used for the treatment of lesion due to physical stimuli, namely, preparations used in thermoplegia and preparations used in radiation sickness; preparations used for the treatment of lesion due to chemical stimuli, namely, anti-benzolismus preparations, anti-arsenism preparations and anti-chlorine poisoning preparations; antibiotics, namely, penicillin and preparations, streptomycin and preparations, chloramphenicol preparations, erythromycin and preparations, thiolutin preparations, tetracycline and preparations, colistin-polymyxin preparations, mixed antibiotic preparations, salkomycin and preparations and trichomycin and preparations; chemotherapeutics, namely, sulfonamide preparations, antituberculotic preparations, antisyphilitics and antiliprotic preparations; preparations against parasites for medical use, namely, antiprozoals and anthelmintics; pharmaceutical preparations for dispensing use, namely, excipients, ointment bases, solvents, flavoring agents, deodorizer and coloring preparations for medical use; narcotics, namely, opium alkaloids, derivatives and preparations, coca alkaloids, derivatives and preparations and synthetic narcotics; preparations for agriculture or public health, namely, disinfectants, insecticides, fumigants, rodenticides, herbicides, moth repellents, deodorants for pharmaceutical preparations which serve as antiseptics; gauze for use as an ear bandage; gauze for use as an eye patch; gauze; liquid bandages; medical oil paper for surgical treatment; menstruation tampons, menstruation bandages, napkins for incontinents, namely, adult diapers; oblate, namely, thin wafers made from wheatmeal or capsules for containing medicaments for pharmaceutical or medical purposes; sanitary napkins; semen for artificial insemination | SECTION 8 - CANCELLED | — |
| 010 | eye patches and sanitary masks | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHILD CO., LTD.
- Other trademarks owned by PHILD CO., LTD.
- Other trademarks owned by PHILD CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named PHILD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 2, 2006 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 9, 2006 | CFIT | CASE FILE IN TICRS | — |
| Nov 16, 2004 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 19, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 29, 2000 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 7, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 7, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 1998 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Dec 28, 1998 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 1, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 1998 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Jun 25, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 1998 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 5, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 1997 | DOCK | ASSIGNED TO EXAMINER | — |